Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.34
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
cancer0.29
Tech stack
AI readiness
AI-Readiness score
44 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
LYMPHIR™ (denileukin diftitox-cxdl) is FDA Approved
Description
LYMPHIR™ (denileukin diftitox-cxdl) is indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma after at least one prior systemic therapy. Read more and sign up for updates.
Final URL
Language
en (html)
Scanned at
2026-07-08 23:42:14